Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Portela, M.A. (María Angustias) | - |
dc.creator | Sanz, A. (Álvaro) | - |
dc.creator | Martínez, M. (Marina) | - |
dc.creator | Centeno, C. (Carlos) | - |
dc.date.accessioned | 2012-05-30T09:58:08Z | - |
dc.date.available | 2012-05-30T09:58:08Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Portela MA, Sanz A, Martinez M, Cortes CC. Astenia en cáncer avanzado y uso de psicoestimulantes. An Sist Sanit Navar 2011 Sep-Dec;34(3):471-479 | es_ES |
dc.identifier.issn | 1137-6627 | - |
dc.identifier.uri | https://hdl.handle.net/10171/22310 | - |
dc.description.abstract | Asthenia is the most frequent symptom in patients with advanced cancer and is probably what most affects the quality of life of oncology patients since it interferes in their physical and social activity. Treatment in the majority of cases is symptomatic. There is growing interest in the use of psychostimulants for treating asthenia. Methylphenidate and modafinil are two psychostimulants that have already been tested in controlled studies on asthenia of the patient with advanced cancer; they have proved to be efficient, particularly in patients in very advanced stages who are very tired. | es_ES |
dc.language.iso | spa | es_ES |
dc.publisher | Gobierno de Navarra. Departamento de Salud | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Fatigue | es_ES |
dc.subject | Asthenia | es_ES |
dc.subject | Cancer | es_ES |
dc.subject | Methylphenidate | es_ES |
dc.title | Astenia en cáncer avanzado y uso de psicoestimulantes | es_ES |
dc.title.alternative | Asthenia in advanced cancer and the use of psychostimulants | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
dc.identifier.pmid | 22233850 | - |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.